ASCO 2011: Steve Joffe Discusses Controversies in Phase I Clinical Trials
Interviewed by the editors of ONCOLOGY August 12, 2011
Steve Joffe, MD discusses the ethical challenges and controversies in phase I clinical cancer trials: how physicians should present these clinical trials to patientsphase I trials typically have very low response rates (5% to 10%)and explain their purpose without exaggerating the likely results.
Cheap Sunny Health & Fitness Foot Massager
